Resonance Health Limited (ASX:RHT)
Australia · Delayed Price · Currency is AUD 0.0590
-0.0030 (-4.84%)
Sep 9, 2026, 3:39 PM AEST
Resonance Health Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 30 | 21 | 18 | 26 | 19 | 26 | |
Market Cap Growth | 92.34% | 17.12% | -32.02% | 36.13% | -25.00% | -63.87% |
Enterprise Value | 29 | 22 | 18 | 21 | 13 | 18 |
Last Close Price | 0.06 | 0.04 | 0.04 | 0.06 | 0.04 | 0.06 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 20.00 | 13.87 | - | 155.74 | - | - |
PS Ratio | 1.88 | 1.33 | 1.62 | 3.07 | 4.40 | 6.70 |
PB Ratio | 2.66 | 1.89 | 1.91 | 2.41 | 1.95 | 2.42 |
P/TBV Ratio | 6.74 | 4.78 | 7.47 | 7.18 | 1.95 | 2.42 |
P/FCF Ratio | 10.62 | 7.53 | 22.26 | 22.77 | - | - |
P/OCF Ratio | 10.27 | 7.29 | 14.36 | 19.01 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 1.81 | 1.42 | 1.63 | 2.42 | 2.99 | 4.75 |
EV/EBITDA Ratio | 11.12 | 9.72 | - | - | - | - |
EV/EBIT Ratio | 15.50 | 12.14 | - | - | - | - |
EV/FCF Ratio | 10.24 | 8.02 | 22.36 | 17.95 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.34 | 0.34 | 0.41 | 0.34 | 0.03 | 0.03 |
Debt / EBITDA Ratio | 1.48 | 1.48 | - | - | - | - |
Debt / FCF Ratio | 1.37 | 1.37 | 4.72 | 3.19 | - | - |
Net Debt / Equity Ratio | -0.09 | -0.09 | 0.09 | -0.29 | -0.61 | -0.61 |
Net Debt / EBITDA Ratio | -0.45 | -0.45 | -0.76 | 7.71 | 4.61 | 4.37 |
Net Debt / FCF Ratio | -0.37 | -0.37 | 1.03 | -2.73 | 13.68 | 4.14 |
Asset Turnover | 0.86 | 0.86 | 0.58 | 0.55 | 0.39 | 0.32 |
Quick Ratio | 1.11 | 1.11 | 1.25 | 1.49 | 8.57 | 9.76 |
Current Ratio | 1.13 | 1.13 | 1.28 | 1.51 | 8.63 | 10.34 |
Return on Equity (ROE) | 14.76% | 14.76% | -17.05% | 1.62% | -7.57% | -10.14% |
Return on Assets (ROA) | 6.28% | 6.28% | -5.06% | -2.11% | -7.50% | -7.90% |
Return on Capital Employed (ROCE) | 15.10% | 15.10% | -12.20% | -3.70% | -13.50% | -14.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 5.12% | 7.21% | -9.67% | 0.64% | -4.03% | -4.42% |
FCF Yield | 9.42% | 13.27% | 4.49% | 4.39% | -2.30% | -6.10% |
Buyback Yield / Dilution | -6.28% | -6.28% | 2.81% | -1.59% | - | -1.97% |